Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-infective, Chemotherapy), By Region, And Segment Forecasts, 2023 - 2030

Research Methodology

A three-pronged approach was followed for deducing the home infusion therapy market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for home infusion therapy market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of home infusion therapy market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Home Infusion Therapy Market Categorization:

The home infusion therapy market was categorized into four segments, namely product (Infusion pumps, Intravenous Sets, IV cannulas, Needleless connectors), application (Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals) and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The home infusion therapy market was segmented into product, application, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The home infusion therapy market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark, Sweden, Norway, Japan; India; China; Australia; South Korea; Thailand, Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE, Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Home infusion therapy market companies & financials:

The home infusion therapy market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• B. Braun Melsungen AG -B. Braun Melsungen AG provides healthcare products and services for anesthesia, emergency care, surgical procedures, extracorporeal blood treatment, and intensive care units. The company operates through four divisions: B. Braun Avitum, Hospital Care, Aesculap, and Out Patient Market. It has more than 260 subsidiaries and manufacturing sites that are located in the U.S., Switzerland, Vietnam, Brazil, and Malaysia. In addition, B. Braun has operations in over 60 countries worldwide. It offers products and therapies pertaining to infusion therapy, laparoscopic surgery, wound management, orthopedic joint replacement, neurology, pain therapy, and nutrition therapy, among others.

• Baxter - Baxter manufactures and distributes pharmaceutical and medical devices for the treatment of kidney diseases, immune disorders, hemophilia, and other chronic & acute health conditions. The company also offers IV solutions products, which are used for drug delivery processes, and inhalation anesthetics for the treatment of irreversible kidney failure & end-stage renal diseases. Baxter operates through two segments: Medical Products and Biosciences. In the Biosciences segment, the company processes plasma-based proteins and recombinants for the treatment of bleeding disorders. Baxter operates in over 27 countries and markets its products in more than 100 countries across the world.

• Fresenius Kabi AG - Fresenius Kabi AG is engaged in medicines and technologies for clinical nutrition, transfusion, and infusion. Its product line comprises clinical nutrition products, infusion therapies, and a comprehensive range of IV generic drugs, as well as medical devices for administration. Further, the company offers solutions for cell therapies, blood collection & storage, and transfusion medicines. The company operates in more than 100 countries worldwide.

• ICU Medical, Inc. - ICU Medical, Inc. develops & markets pharmaceuticals & medical devices as well as technologies used in critical care applications, oncology, and vascular therapy. The company’s product line comprises innovative hemodynamic monitoring systems, needle-free closed blood sampling systems, advanced sensor catheters, closed-system hazardous drug handling devices & systems, custom infusion sets, and needle-free vascular access devices. The company specializes in nursing, medical devices, emergency care, infection control, healthcare informatics, patient safety, IV therapy, closed system transfer devices, IV workflow software, IV safety software, IV smartpumps, CSTDs, needle-less IV solutions, IV nutritionals, and pharmaceuticals.

• JMS Co. Ltd. - JMS Co. Ltd. Manufactures and distributes semisolid nutrition feeding devices for infusion & transfusion therapies, syringe pumps, infusion pumps, oral/enteral nutrition systems, extension tubes, safety venous indwelling catheters, safety scalp vein sets, disposable needles & syringes, infusion sets with needleless access port, and transfusion & infusion sets. Moreover, the company offers hemodialysis machines, central dialysate delivery systems, safety Arteriovenous (AV) fistula needles, hemodialysis blood tubing sets, hemodialysis kits, and dialysis solutions for CAPD.

• Smiths Medical - Smiths Medical develops, manufactures, and supplies medical devices and specializes in delivering equipment for hospital, home, emergency, and specialty settings. It also offers emergency healthcare solutions for homeland, defense, and medical-grade tubing products for industrial use. Moreover, the company offers veterinary devices, OEM services, medical device solutions for preclinical & clinical research, and monitoring & respiratory equipment. Smiths Medical offers products via its sales and distribution network in the U.S. as well as internationally. The company’s manufacturing facilities are located in the U.S., the UK, Mexico, and Italy.

• Terumo Corporation - Terumo Corporation manufactures, distributes, and supplies medical devices & accessories across the world. The company also offers endovascular therapy solutions, blood management systems, and hollow-fiber technology solutions. Terumo Corporation’s Terumo Interventional Systems (TIS) is known for its leadership in embolization solutions, minimally invasive entry site management, and lesion access. The company has operations in more than 160 countries worldwide.

• Becton, Dickinson and Company - Becton, Dickinson and Company offers medical technology solutions across the globe. The company develops, manufactures, and sells a wide range of diagnostic products, devices, laboratory equipment, and medical products. It offers products to general public, clinical laboratories, life science researchers, healthcare institutions, and pharmaceuticals industry. The company operates through two business segments—BD Life Sciences and BD Medical. It has headquarters in the U.S. and presence in Europe, Greater Asia, Canada, the MEA, and Latin America.

• Coram LLC - Coram LLC offers infusion therapies & services to patients through a network of more than 85 locations, including 65 ambulatory infusion suites. The company provides infusion services pertaining to anti-infectives, nutrition, inotropes, Immunoglobulin (Ig), alpha-1, pre- & post-transplant, hemophilia, and pain & palliative care to all age groups. In addition, Coram LLC provides patient education, along with therapies, to patients and their family members.

• Option Care Health, Inc. - Option Care Health, Inc. is a major provider of alternate treatment site and home infusion therapy services. The company’s service offerings include administration & distribution of injectable & infused medications, clinical & compliance management, reimbursement support, and patient care coordination. It offers services to pharmaceutical manufacturers, patients, physicians, managed care organizations, and other third parties. In addition, the company provides specialized therapies & services, Ig infusion therapy solutions, and nutrition support, among others. The company serves over 100 alternate treatment sites and more than 85 infusion pharmacies. 

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Home Infusion Therapy Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2020, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Home Infusion Therapy Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.